|
|
Volumn 18, Issue 11, 2012, Pages 1639-1642
|
|
Identification of the molecular basis of doxorubicin-induced cardiotoxicity
a
b,c
a
b
d
d
a,b
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
APOPTOTIC PROTEASE ACTIVATING FACTOR 1;
DNA TOPOISOMERASE;
DOXORUBICIN;
FAS ANTIGEN;
MESSENGER RNA;
PROTEIN BAX;
PROTEIN MDM2;
PROTEIN P53;
PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE;
REACTIVE OXYGEN METABOLITE;
SUCCINATE DEHYDROGENASE;
TOPOISOMERASE IIBETA;
TRANSCRIPTOME;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL TISSUE;
ARTICLE;
DOUBLE STRANDED DNA BREAK;
DOWN REGULATION;
GENE DELETION;
GENE EXPRESSION;
HEART FAILURE;
HEART MITOCHONDRION;
HEART MUSCLE CELL;
HEART MUSCLE OXYGEN CONSUMPTION;
MOUSE;
NONHUMAN;
NUCLEOTIDE SEQUENCE;
PRIORITY JOURNAL;
ANIMALS;
APOPTOSIS;
CARDIOTOXINS;
DNA TOPOISOMERASES, TYPE II;
DNA-BINDING PROTEINS;
DOXORUBICIN;
HEART FAILURE;
HUMANS;
MICE;
MITOCHONDRIAL TURNOVER;
MYOCYTES, CARDIAC;
REACTIVE OXYGEN SPECIES;
SEQUENCE DELETION;
MUS;
|
|
EID: 84869209094
PISSN: 10788956
EISSN: 1546170X
Source Type: Journal
DOI: 10.1038/nm.2919 Document Type: Article |
|
Times cited : (1460)
|
|
References (24)
|
